Serum S100B levels in patients with cerebral and extracerebral infectious disease

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 1, 2004, Pages 10-13

  Undén, Johan ^a   Christensson, Bertil ^a   Bellner, Johan ^a   Alling, Christer ^a   Romner, Bertil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S100B;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; BLOOD ANALYSIS; BLOOD SAMPLING; BORRELIA; BORRELIA INFECTION; BRAIN ABSCESS; BRAIN INFECTION; CAMPYLOBACTER; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS VIRUS; ENTERITIS; EPSTEIN BARR VIRUS; ERYSIPELAS; GRAM NEGATIVE BACTERIUM; HERPES SIMPLEX VIRUS; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; LISTERIA MONOCYTOGENES; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; NEUROLOGIC DISEASE; PNEUMONIA; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; SALMONELLA; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; VIRUS ENCEPHALITIS; VIRUS MENINGITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; COMMUNICABLE DISEASES; FEMALE; HUMANS; MALE; MENINGITIS, BACTERIAL; MENINGITIS, VIRAL; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; RETROSPECTIVE STUDIES; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 1242274552     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310017294     Document Type: Article

References (25)

1. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Common 1965; 19: 739-44.
2. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33: 637-68.
3. Jonsson H, Johnsson P, Hoglund P, Alling C, Blomquist S. Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 2000; 14: 698-701.
4. Wiesmann M, Missler U, Gottmann D, Gehring S. Plasma S100b protein concentration in healthy adults is age- and sex-independent. Clin Chem 1998; 44: 1056-8.
5. Bottiger BW, Mobes S, Glatzer R, Bauer H, Gries A, Bartsch P, et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001; 103: 2694-8.
6. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000; 31: 2670-7.
7. Ingebrigtsen T, Romner B. Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury. Case report. J Neurosurg 1996; 85: 945-8.
8. Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj 2000; 14: 1047-55.
9. Ingebrigtsen T, Romner B. Biochemical serum markers of traumatic brain injury. J Trauma 2002; 52: 798-808.
10. Jonsson H, Johnsson P, Alling C, Backstrom M, Bergh C, Blomquist S. S100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg 1999; 68: 2202-8.
11. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery 1999; 45: 477-83.
12. Romner B, Ingebrigtsen T, Kongstad P, Borgesen SE. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma 2000; 17: 641-7.
13. Rothoerl RD, Woertgen C, Brawanski A. S-100 serum levels and outcome after severe head injury. Acta Neurochir Suppl 2000; 76: 97-100.
14. Townend WJ, Guy MJ, Pani MA, Martin B, Yates DW. Head injury outcome prediction in the emergency department: a role for protein S-100B? J Neurol Neurosurg Psychiatry 2002; 73: 542-6.
15. Wiesmann M, Missler U, Hagenstrom H, Gottmann D. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir 1997; 139: 1155-60.
16. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480-4.
17. Hirose Y, Mokuno K, Wakai M, Takahashi A, Hashizume Y, Yanagi T, Kato K. Elevated cerebrospinal fluid levels of manganese superoxide dismutase in bacterial meningitis. J Neurol Sci 1995; 131: 51-7.
18. Fagnart OC, Sindic CJ, Laterre C. Particle counting immunoassay of S100 protein in serum. Possible relevance in tumours and ischaemic disorders of the central nervous system. Clin Chem 1988; 34: 1387-91.
19. Infante JR, Torres-Avisbal M, Martinez A, Vallejo JA, Aguilera C, Contreras P, et al. Evaluation of tumour marker S-100 in cerebrospinal fluid from subjects with non-ischaemic brain pathologies. Tumour Biol 2000; 21: 38-45.
20. Studahl M, Rosengren L, Gunther G, Hagberg L. Difference in pathogenesis between Herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J Neurol 2000; 247: 636-42.
21. Sindic CJ, Kevers L, Chalon MP, Laterre EC, Masson PL. Monitoring and tentative diagnosis of herpetic encephalitis by protein analysis of cerebrospinal fluid. Particular relevance of the assays of ferritin and S-100. J Neurol Sci 1985; 67: 359-69.
22. Bertsch T, Casarin W, Kretschmar M, Zimmer W, Walter S, Sommer C, et al. Protein S-100B: a serum marker for ischaemic and infectious injury of cerebral tissue. Clin Chem Lab Med 2001; 39: 319-23.
23. Lamers KJ, van Engelen BG, Gabreels FJ, Hommes OR, Borm GF, Wevers RA. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders. Acta Neurol Scand 1995; 92: 247-51.
24. Mokuno K, Kato K, Kawai K, Matsuoka Y, Yanagi T, Sobue I. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 1983; 60: 443-51.
25. Regner A, Bianchini O, Jardim C, Menna-Barreto M. HTLV-I-associated myelopathy: are ferritin, S100beta protein, or guanine nucleotides CSF markers of disease? J Neurovirol 2002; 8: 64-7.